Title:
Serotonin 2B receptor antagonism agent
Document Type and Number:
Japanese Patent JP6265126
Kind Code:
B2
Abstract:
The purpose of the present invention is to provide a 5-HT2B receptor antagonist which does not induce problematic adverse side effects or the like and can be used safely. Provided are a serotonin 2B receptor antagonist and a prophylactic or therapeutic agent for diseases associated with abnormal signal transduction from a serotonin 2B receptor, each of which is characterized by comprising ethenzamide.
Inventors:
Takahito Nikaido
Minako Imai
Minako Imai
Application Number:
JP2014540881A
Publication Date:
January 24, 2018
Filing Date:
October 10, 2013
Export Citation:
Assignee:
Taisho Pharmaceutical Co., Ltd.
International Classes:
A61K31/166; A61K45/00; A61P1/00
Domestic Patent References:
| JP2005139172A | ||||
| JP2010155802A | ||||
| JP2002348277A |
Other References:
日本緩和医療学会,がん疼痛の薬物療法に関するガイドライン(2010年版),第2章第1項第2.欄の表10
耳展,1997年,40(2),p.227-230,特にp.227の2.1)欄
GASTROENTEROLOGY,2009年,137(1),p.94-100,特にp.97の右欄第2パラグラフ
祖父江逸郎ら,NWT‐384(ノーシンホワイト錠)の頭痛に対する臨床効果,月刊臨床と研究,1988年,65(4),p.275-286
Po-Jen Wang et. al.,Frequent analgesics consumption in migraineurs: comparison between chronic and episodic migraineurs,J Headache Pain,2004年,5(1),p.30-35
耳展,1997年,40(2),p.227-230,特にp.227の2.1)欄
GASTROENTEROLOGY,2009年,137(1),p.94-100,特にp.97の右欄第2パラグラフ
祖父江逸郎ら,NWT‐384(ノーシンホワイト錠)の頭痛に対する臨床効果,月刊臨床と研究,1988年,65(4),p.275-286
Po-Jen Wang et. al.,Frequent analgesics consumption in migraineurs: comparison between chronic and episodic migraineurs,J Headache Pain,2004年,5(1),p.30-35
Attorney, Agent or Firm:
Ono International Patent Office